Prosthetic valve endocarditis caused by Pseudomonas luteola by Casalta, Jean-Paul et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
BMC Infectious Diseases
Open Access Case report
Prosthetic valve endocarditis caused by Pseudomonas luteola
Jean-Paul Casalta*1, Pierre-Edouard Fournier1, Gilbert Habib2, 
Alberto Riberi3 and Didier Raoult1
Address: 1Laboratoire de Microbiologie, IFR 48, Centre Hospitalier-Universitaire de La Timone,264 rue Saint Pierre, Marseille, France, 2Service de 
Cardiologie, Centre Hospitalier Universitaire de La Timone, Marseille, France and 3Service de Chirurgie Cardiaque, Centre Hospitalier 
Universitaire de La Timone, Marseille, France
Email: Jean-Paul Casalta* - jean-paul.casalta@wanadoo.fr; Pierre-Edouard Fournier - Pierre-Edouard.Fournier@medecine.univ-mrs.fr; 
Gilbert Habib - gilbert.habib@ap-hm.fr; Alberto Riberi - alberto.riberi@ap-hm.fr; Didier Raoult - didier.raoult@medecine.univ-mrs.fr
* Corresponding author    
Abstract
Background: Pseudomonas luteola has been recognized as an uncommon cause of bacteremia and
of infections in patients with underlying medical disorders
Case presentation: We isolated P. luteola from blood cutures in a patient with prosthetic valve
endocarditis developed 16 months after cardiac surgery.
Conclusion:  P. luteola is a rare opportunistic agent, with a propensity of infecting valvular
prostheses.
Background
Pseudomonas luteola (P. luteola) is an aerobic, Gram-nega-
tive rod with a distinctive yellow to orange pigment. After
48 hours of incubation, colonies are typically rough or
wrinkled. The organism is non-fermentative, oxidase-neg-
ative, catalase-positive, and grows on MacConkey agar [1].
The organism was originally named P. luteola. On the
basis of low levels of DNA- DNA hybridization, it was
subsequently reclassified as Chryseomonas luteola [1].
Anzai et al. [2], in an analysis of 16S rDNA sequences of
these organisms, has suggested that genus names Chryse-
omonas, Flavimonas and Pseudomonas were synonymous.
Consequently, they concluded that the names P. luteola
and Pseudomonas oryzihabitans should be used. The normal
habitat of P. luteola is unclear, although it belongs to a
group of bacteria normally found in water, soil, and other
damp environments [3,4]. Reported human infections are
rare.
Case presentation
In July 2003, a 53-year-old man was admitted to the
Timone hospital in Marseilles, France, presenting with
clinical signs of acute endocarditis. He had a fever of 39°C
that lasted for two weeks, anorexia, a weight loss of 7 kg
since December 2002, a stroke with intracranial haemor-
rhage, and femoral arterial emboli. He had had an aortic
replacement by a bioprosthesis in March 2002 for aortic
insufficiency. In February 2003, the patient was hospital-
ized for undulating fever (38.5°C) that had lasted for the
previous 3 months. The transeosophageal echocardiogra-
phy showed neither valvular dysfunction nor vegetation.
Six blood cultures were negative. The patient was treated
with amoxicillin (1 g twice a day orally) for 8 days. The
fever decreased but persisted at a level of 37.8°C. In July
2003, upon his admission, the echocardiography (multi-
plane transesophageal echocardiography) showed a vege-
tation on the aortic bioprothesis valve measuring 30 mm
at its maximum, and a grade IV valvular regurgitation. The
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white blood cell count was of 14.36 × 109/L (92.7% poly-
morphonuclears, 5.0% lymphocytes, 2.3% monocytes),
the haemoglobin level was of 90 g/L, the erythrocyte sed-
imentation rate (ESR) was of 50 mm/h (first hour), the C
reactive protein level was of 208 mg/l. No rheumatoid fac-
tor was detected. All three aerobic blood cultures, as well
as the removed femoral arterial thrombus yielded Pseu-
domonas luteola (P. luteola) within 48 h of culture. The
microorganism was identified using both the API 20 E
(Biomerieux,Marcy l'Etoile, France) and API 20 NE galer-
ies (Biomerieux). The identification was confirmed by
sequencing its 16S rDNA using the fD1 (AGAGTTTGATC-
CTGGCTCAG) and rP2 (ACGGCTACCTTGTTACGACTT)
primers as previously described [2,5-7]. The nucleotide
sequence (GenBank accession number AY574976) was
compared with sequences available in GenBank using the
BLAST version 2.2.9 software (National Center for Bio-
technology Information) and showed 99.7% similarity
with the 16S rDNA sequence of P. luteola (GenBank acces-
sion number D84002). The patient's isolate was suscepti-
ble to ampicillin, ureidopenicillin, third-generation
cephalosporins, fluoroquinolones, and aminoglycosides.
The patient was treated intravenously with ticarcillin + cla-
vulanic acid (3 g five times per day) for 60 days, and gen-
tamicin (210 mg once a day) for 15 days. The high dose of
ticarcillin + clavulanic acid was justified by the cerebral
involvement. In the course of antibiotic therapy, the fever
resumed and the patient's condition improved. However,
worsening aortic insufficiency led to the replacement of
the aortic bioprothetic valve 76 days following admission.
Macroscopic examination of the removed valve showed
extensive aortic vegetation. Microscopic examination
showed features typical of infectious endocarditis [8]. The
bacterial culture of the valve was negative. The 16S rDNA
PCR performed on valvular tissue was negative. Following
cardiac surgery under extracorporeal circulation, the
patient developed haemodynamic instability and renal
insufficiency that required a prolonged hospitalization.
The patient was released from hospital in February 2004,
7 months following admission.
Reported human P. luteola infections are rare. These have
included a septicemia in a patient with systemic lupus ery-
thematosus under corticosteroid therapy who developed
haemorrhagic pancreatitis complicated by a pancreatic
abscess [5]; one case of bacteremia in a previously healthy
patient with granulomatous hepatitis [9]; a bacteremia in
a patient with peritonitis [10]; and non-bacteremic cases
of peritonitis associated with gangrenous appendititis
[10] and continuous ambulatory peritoneal dialysis [11].
Bacteremia has also been reported in patients with ind-
welling vascular catheters [10-12]. Other clinical isolates
have been recovered from the bone of a patient with a
femur abscess [10]; from a patient with a subphrenic
abscess [10]; from the cerebrospinal fluid and wounds of
neurosurgical patients with dural grafts or bone flaps [13];
from an HIV-infected patient with invasive cutaneous
infection [3]; and from a patient with facial cellulitis [11].
To the best of our knowledge, only two cases of endocar-
ditis caused by P. luteola have been reported in patients
with prosthetic cardiac valves [13,14]. These patients had
developed fever and blood cultures grew P. luteola 15 days
[13] and 45 days [14], respectively, after cardiac surgery.
In addition, one case of P. luteola septicemia has been
described in a 5-month-old infant after open heart surgery
for congenital cardiac disease [3]. Septicemia was diag-
nosed 8 days after surgery but no endocarditis was found.
In the present case, as the patient did not undergo any
invasive procedure between the 2002 valvular replace-
ment and the onset of fever, we believe that he was
infected during the initial cardiac surgery.
Conclusion
Using the Duke endocarditis service criteria, our patient
was classified as having a definite endocarditis (valvular
histological examination confirmed the diagnosis of
infectious endocarditis). The isolation of P. luteola in 3
blood cultures and in the arterial thrombus demonstrated
its role as an etiologic agent. Including our patient, endo-
carditis with P. luteola has occurred in three patients who
had undergone valvular replacement. This suggests that
this organism is a rare opportunistic agent, with a propen-
sity of infecting valvular prostheses.
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